Physician profile
Scott M Odonnell
NPI 1205058799
$546.00
in general payments reported to CMS, 2019-2025
13 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2023: $22.76 · 2024: $68.54 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $226.27 | 2019 | |
| Seqirus USA INC | $44.48 | 2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $44.04 | 2023-2024 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Cranial Technologies, INC | $33.13 | 2025 | Doc Band |
| Alk-Abello, INC | $31.88 | 2025 | Neffy |
| Ars Pharmaceuticals Operations, INC. | $27.60 | 2025 | Neffy |
| Verrica Pharmaceuticals INC. | $24.90 | 2024 | Ycanth |
| Ironshore Pharmaceuticals INC. | $23.14 | 2019 | |
| Pfizer INC. | $22.36 | 2024 | |
| Shire North American Group INC | $20.59 | 2019 | |
| Corium, LLC | $19.26 | 2025 | Azstarys |
| Lnhc, INC | $14.77 | 2025 | Zelsuvmi |
| Phadia US INC. | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Odonnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.